The efficacy and safety of electroacupuncture in the treatment of Alzheimer's disease

Guang'anmen Hospital, China Academy of Chinese Medicine Sciences0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Meet the DSM-IV-R diagnostic criteria for dementia;
•2. Meet the diagnostic criteria for probable AD in the NIA-AA criteria;
•3. Aged 50 to 85 years;
•4. Clinical dementia assessment score >= 0.5 points, MMSE score <= 26 points;
•5. Hachinski ischemia scale score<=4 points;
•6. It is allowed to have received ordinary acupuncture and electro-acupuncture before screening, but has not received electro-acupuncture in the past two weeks;
•7. If the subject has the ability to make a decision, he/she shall sign the informed consent; if the patient's educational level is low and unable to sign the informed consent, the legal guardian shall sign the informed consent;
•8. Caregivers or family members (guarantee to accompany the patient for >=3 hours a day, >=3 days a week) sign informed consent.

•1. Accompanied by severe cerebrovascular disease;
•2. Associated with other neurological or non-neurological diseases that can cause cognitive dysfunction or progressive memory impairment;
•3. Drug-induced cognitive dysfunction or progressive memory impairment;
•4. Inpatient or moderately high dependency nursing facility;
•5. Patients with severe fear of needles, fainting of needles, and severe skin infections;
•6. Patients with severe cardiovascular disease, malignant tumor, severe liver and kidney insufficiency;
•7. Currently participating in other clinical trials.

发起方

Guang'anmen Hospital, China Academy of Chinese Medicine Sciences